{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:33:11Z","timestamp":1787502791636,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Netherlands Lung Fund","award":["3.2.10.069"],"award-info":[{"award-number":["3.2.10.069"]}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["CRT 114696"],"award-info":[{"award-number":["CRT 114696"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Eosinophils drive pathophysiology in stable and exacerbating eosinophilic asthma, and therefore treatment is focused on the reduction of eosinophil numbers. Mepolizumab, a humanized monoclonal antibody that neutralizes IL-5 and efficiently attenuates eosinophils, proved clinically effective in severe eosinophilic asthma but not in mild asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To study the effect of mepolizumab on virus-induced immune responses in mild asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with mild asthma, steroid-naive and randomized for eosinophil numbers, received 750 mg mepolizumab intravenously in a placebo-controlled double-blind trial, 2 weeks after which patients were challenged with rhinovirus (RV) 16. FEV1, FVC, fractional exhaled nitric oxide, symptom scores (asthma control score), viral load (PCR), eosinophil numbers, humoral (luminex, ELISA), and cellular (flow cytometry) immune parameters in blood, BAL fluid, and sputum, before and after mepolizumab and RV16, were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Mepolizumab attenuated baseline blood eosinophils and their activation, attenuated trendwise sputum eosinophils, and enhanced circulating natural killer cells. Mepolizumab did not affect FEV1, FVC, and fractional exhaled nitric oxide, neither at baseline nor after RV16. On RV16 challenge mepolizumab did not prevent eosinophil activation but did enhance local B lymphocytes and macrophages and reduce neutrophils and their activation. Mepolizumab also enhanced secretory IgA and reduced tryptase in BAL fluid. Finally, mepolizumab affected particularly RV16-induced macrophage inflammatory protein-3a, vascular endothelial growth factor-A, and IL-1RA production in BAL fluid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mepolizumab failed to prevent activation of remaining eosinophils and changed RV16-induced immune responses in mild asthma. Although these latter effects likely are caused by attenuated eosinophil numbers, we cannot exclude a role for basophils.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT 01520051).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201803-0461oc","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T16:00:07Z","timestamp":1536336007000},"page":"508-517","source":"Crossref","is-referenced-by-count":86,"title":["Anti\u2013IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study"],"prefix":"10.1093","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-9058","authenticated-orcid":false,"given":"Yanaika S.","family":"Sabogal Pi\u00f1eros","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine"},{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Bal","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"},{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A.","family":"van de Pol","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Dierdorp","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Dekker","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Dijkhuis","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brinkman","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen F.","family":"van der Sluijs","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Bioinformatics, and Biostatistics, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof J.","family":"Majoor","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Bonta","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Ravanetti","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"},{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Sterk","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Lutter","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine"},{"name":"Department of Experimental Immunology (Amsterdam Infection & Immunity Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"2026030321253632400_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaci.2014.12.1871","article-title":"Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care","volume":"135","author":"Fajt","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321253632400_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"2026030321253632400_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026030321253632400_bib4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"2026030321253632400_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12016-015-8526-3","article-title":"The role and immunobiology of eosinophils in the respiratory system: a comprehensive review","volume":"50","author":"Eng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026030321253632400_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"2026030321253632400_bib7","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"2026030321253632400_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mi.2015.2","article-title":"Eosinophils in mucosal immune responses","volume":"8","author":"Travers","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2026030321253632400_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4049\/jimmunol.160.3.1279","article-title":"Eosinophils bind rhinovirus and activate virus-specific T cells","volume":"160","author":"Handzel","year":"1998","journal-title":"J Immunol"},{"key":"2026030321253632400_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood-2013-05-502443","article-title":"Activated mouse eosinophils protect against lethal respiratory virus infection","volume":"123","author":"Percopo","year":"2014","journal-title":"Blood"},{"key":"2026030321253632400_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.70.5.691","article-title":"Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens","volume":"70","author":"Rosenberg","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2026030321253632400_bib12","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/jcb.24187","article-title":"An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity","volume":"113","author":"Sikriwal","year":"2012","journal-title":"J Cell Biochem"},{"key":"2026030321253632400_bib13","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.1600787","article-title":"Eosinophils promote antiviral immunity in mice infected with influenza A virus","volume":"198","author":"Samarasinghe","year":"2017","journal-title":"J Immunol"},{"key":"2026030321253632400_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2015-0405OC","article-title":"Human and mouse eosinophils have antiviral activity against parainfluenza virus","volume":"55","author":"Drake","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026030321253632400_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/all.13057","article-title":"An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model","volume":"72","author":"Ravanetti","journal-title":"Allergy"},{"key":"2026030321253632400_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.161.1.9809100","article-title":"Changes in sputum eosinophils predict loss of asthma control","volume":"161","author":"Jatakanon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321253632400_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/ajrccm.161.3.9809071","article-title":"Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma","volume":"161","author":"Norzila","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321253632400_bib18","first-page":"A1196","article-title":"Anti-IL5 treatment alters eosinophil responses to a rhinovirus-16 challenge in mild asthma patients and also that of neutrophils, macrophages and B cells [abstract]","volume":"197","author":"Sabogal Pi\u00f1eros","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321253632400_bib19","first-page":"482","article-title":"Activation states of blood eosinophils in asthma","volume-title":"Clin Exp Allergy","author":"Johansson","year":"2014"},{"key":"2026030321253632400_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2013.00222","article-title":"Secretory IgA: designed for anti-microbial defense","volume":"4","author":"Brandtzaeg","year":"2013","journal-title":"Front Immunol"},{"key":"2026030321253632400_bib21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321253632400_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fimmu.2017.00510","article-title":"The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of natural cytotoxicity receptors with eosinophil surface ligands","volume":"8","author":"Pesce","year":"2017","journal-title":"Front Immunol"},{"key":"2026030321253632400_bib23","doi-asserted-by":"crossref","first-page":"27615","DOI":"10.1038\/srep27615","article-title":"Natural killer cells regulate eosinophilic inflammation in chronic rhinosinusitis","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"2026030321253632400_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1164\/rccm.201611-2234OC","article-title":"Mepolizumab attenuates airway eosinophil numbers, but not their functional phenotype, in asthma","volume":"196","author":"Kelly","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321253632400_bib25","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1164\/ajrccm.164.supplement_2.2106065","article-title":"Angiogenesis and remodeling of airway vasculature in chronic inflammation","volume":"164","author":"McDonald","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321253632400_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.279.5349.381","article-title":"Chemokines and the arrest of lymphocytes rolling under flow conditions","volume":"279","author":"Campbell","year":"1998","journal-title":"Science"},{"key":"2026030321253632400_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cyto.2006.02.003","article-title":"Action of intracellular IL-1Ra (type 1) is independent of the IL-1 intracellular signalling pathway","volume":"33","author":"Evans","year":"2006","journal-title":"Cytokine"},{"key":"2026030321253632400_bib28","first-page":"591","article-title":"Effect of vascular endothelial growth factor and its receptor KDR on human airway smooth muscle cells proliferation","volume":"118","author":"Zou","year":"2005","journal-title":"Chin Med J (Engl)"},{"key":"2026030321253632400_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.iac.2014.01.013","article-title":"Eosinophilia in mast cell disease","volume":"34","author":"Kovalszki","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"2026030321253632400_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/thx.2005.056093","article-title":"Exhaled nitric oxide measurements: clinical application and interpretation","volume":"61","author":"Taylor","year":"2006","journal-title":"Thorax"},{"key":"2026030321253632400_bib31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/COPD.S134998","article-title":"Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD","volume":"12","author":"Gao","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026030321253632400_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"2026030321253632400_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000024040","article-title":"Regulation of IL-5 and IL-5 receptor expression in the bone marrow of allergic asthmatics","volume":"118","author":"Denburg","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"2026030321253632400_bib34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of \u03b1-tryptase and \u03b2-tryptase by human basophils","volume":"113","author":"Jogie-Brahim","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321253632400_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/cyto.a.22472","article-title":"Identification and quantification of basophils in the airways of asthmatics following segmental allergen challenge","volume":"85","author":"Dijkstra","year":"2014","journal-title":"Cytometry A"},{"key":"2026030321253632400_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1398-9995.2004.00606.x","article-title":"Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro","volume":"59","author":"Dahl","year":"2004","journal-title":"Allergy"},{"key":"2026030321253632400_bib37","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1073\/pnas.0804181105","article-title":"Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1\/2 cytokine and IL-10 production","volume":"105","author":"Message","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321253632400_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/199\/4\/508\/67182173\/ajrccm_199_4_508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/199\/4\/508\/67182173\/ajrccm_199_4_508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:25:47Z","timestamp":1772591147000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/199\/4\/508\/8497825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201803-0461oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2]]}}}